Omega Healthcare Investors (NYSE:OHI – Get Free Report) issued an update on its FY 2026 earnings guidance on Wednesday morning. The company provided earnings per share guidance of 3.220-3.260 for the period, compared to the consensus EPS estimate of 3.100. The company issued revenue guidance of -.
Omega Healthcare Investors Stock Down 0.8%
NYSE OHI traded down $0.41 on Friday, hitting $49.98. 241,378 shares of the stock traded hands, compared to its average volume of 2,122,623. The company has a market capitalization of $14.89 billion, a P/E ratio of 17.85, a price-to-earnings-growth ratio of 2.19 and a beta of 0.58. Omega Healthcare Investors has a twelve month low of $38.71 and a twelve month high of $52.39. The stock has a 50-day moving average of $47.69 and a 200 day moving average of $46.64. The company has a current ratio of 5.32, a quick ratio of 5.32 and a debt-to-equity ratio of 0.81.
Omega Healthcare Investors (NYSE:OHI – Get Free Report) last announced its earnings results on Wednesday, July 29th. The real estate investment trust reported $1.19 earnings per share for the quarter, beating the consensus estimate of $0.51 by $0.68. The firm had revenue of $328.25 million for the quarter, compared to the consensus estimate of $266.97 million. Omega Healthcare Investors had a return on equity of 15.96% and a net margin of 66.96%.The firm’s revenue for the quarter was up 16.2% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.77 EPS. Omega Healthcare Investors has set its FY 2026 guidance at 3.220-3.260 EPS. As a group, analysts expect that Omega Healthcare Investors will post 3.09 earnings per share for the current fiscal year.
Omega Healthcare Investors Increases Dividend
Analyst Ratings Changes
A number of research analysts have recently issued reports on the stock. Royal Bank Of Canada lifted their target price on shares of Omega Healthcare Investors from $47.00 to $48.00 and gave the company a “sector perform” rating in a research note on Monday, May 4th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $56.00 price target (up from $52.00) on shares of Omega Healthcare Investors in a report on Friday. Weiss Ratings upgraded Omega Healthcare Investors from a “buy (b)” rating to a “buy (b+)” rating in a research report on Tuesday, June 30th. Wells Fargo & Company boosted their price objective on Omega Healthcare Investors from $47.00 to $49.00 and gave the stock an “equal weight” rating in a report on Monday, June 1st. Finally, BMO Capital Markets restated a “market perform” rating and set a $52.00 target price on shares of Omega Healthcare Investors in a research report on Monday, May 4th. Five equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, Omega Healthcare Investors presently has a consensus rating of “Hold” and an average price target of $48.79.
View Our Latest Stock Report on Omega Healthcare Investors
Institutional Inflows and Outflows
A number of hedge funds have recently modified their holdings of the company. Invesco Ltd. lifted its position in shares of Omega Healthcare Investors by 101.7% in the third quarter. Invesco Ltd. now owns 4,944,921 shares of the real estate investment trust’s stock worth $208,775,000 after purchasing an additional 2,493,877 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC bought a new stake in Omega Healthcare Investors during the fourth quarter worth about $93,476,000. Daiwa Securities Group Inc. raised its holdings in Omega Healthcare Investors by 84.6% during the third quarter. Daiwa Securities Group Inc. now owns 3,058,031 shares of the real estate investment trust’s stock worth $129,110,000 after acquiring an additional 1,401,066 shares in the last quarter. State Street Corp boosted its position in Omega Healthcare Investors by 4.8% during the second quarter. State Street Corp now owns 14,591,873 shares of the real estate investment trust’s stock valued at $534,792,000 after purchasing an additional 671,473 shares during the last quarter. Finally, AQR Capital Management LLC grew its stake in Omega Healthcare Investors by 21.1% in the second quarter. AQR Capital Management LLC now owns 3,464,943 shares of the real estate investment trust’s stock valued at $126,263,000 after purchasing an additional 602,826 shares in the last quarter. 65.25% of the stock is currently owned by institutional investors.
About Omega Healthcare Investors
Omega Healthcare Investors, Inc is a real estate investment trust (REIT) that specializes in the ownership and management of healthcare-related facilities. The company’s core business involves acquiring and leasing long-term care properties, including skilled nursing facilities and assisted living communities, under net lease agreements. Its portfolio is designed to provide stable, inflation-protected cash flows from operators responsible for day-to-day property management.
Founded in 1992 and headquartered in Hunt Valley, Maryland, Omega Healthcare Investors has grown its holdings to encompass hundreds of facilities across the United States, with a smaller presence in select international markets.
Further Reading
- Five stocks we like better than Omega Healthcare Investors
- Peeling Out or Breaking Down? Ford’s High-Stakes Turnaround
- Generac’s AI Power Story Is Becoming Bigger Than the Weather
- Everyone’s Focused on China—But That’s Not ASML’s Biggest Risk
- Chipotle Mexican Grill Stock Rallies as Q2 Results Top Fears, Guidance Rises
Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.
